文献速递围术期管理与 ERAS

再次冠状动脉旁路移植术中桥血管选择的全国趋势

National trends in conduit selection for redo coronary arterial bypass grafting.
PubMed 文献 · Surgery · 2026-01-08

基于2016—2021年美国全国再入院数据库的回顾性分析,共纳入928,925例成人孤立性冠状动脉旁路移植患者,其中5.3%为再次手术。研究发现再次手术者并发症更多、住院更长(β + 6.2天)、费用更高(β + $11,100),但院内死亡风险经校正后更低(aOR 0.75);内乳动脉使用与死亡风险降低独立相关(aOR 0.57)。

要点

  • 再次冠状动脉旁路移植占5.3%,并发症与资源消耗高于首次手术
  • 校正后再次手术院内死亡风险更低(aOR 0.75),或与患者选择和围术期管理有关
  • 内乳动脉使用与死亡风险降低独立相关(aOR 0.57)

核心结论

  • 再次冠状动脉旁路移植在全国范围内小幅增加,发病率与资源使用高于首次手术,但校正后死亡率更低。
  • 动脉桥血管尤其是内乳动脉的使用可能带来生存获益,值得在再次手术情境中进一步研究。

研究设计与样本

  • 使用2016—2021年Nationwide Readmissions Database的回顾性队列研究。
  • 纳入成人孤立性冠状动脉旁路移植患者,分为首次手术组与再次手术组,共928,925例。
  • 主要结局为院内死亡,次要结局包括围术期并发症、术后住院时间、住院费用、非居家出院和30天非计划再入院。

主要发现

  • 928,925例中5.3%接受再次冠状动脉旁路移植。
  • 2016至2021年,两队列中内乳动脉、桡动脉和大隐静脉的使用均增加(P < .001)。
  • 再次手术与并发症风险更高、住院时间更长(β + 6.2天)和费用更高(β + $11,100)相关。
  • 再次手术与院内死亡校正后比值比0.75相关;内乳动脉使用与死亡校正后比值比0.57相关。

临床怎么用

  • 再次冠状动脉旁路移植患者围术期应关注并发症防控与资源准备,住院时间和费用预期高于首次手术。
  • 桥血管选择上可优先考虑内乳动脉等动脉桥血管,以可能降低死亡风险。

局限性

  • 为基于全国再入院数据库的回顾性分析,存在编码与混杂偏倚可能。
  • 再次手术死亡率更低可能反映患者选择与围术期管理差异,不能直接推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Redo coronary arterial bypass grafting is a high-risk operation associated with significant morbidities. Although conduit selection remains a critical factor influencing post-coronary arterial bypass grafting outcomes, the trends in vessel utilization in redo operations remain poorly characterized. We used a nationally representative database to examine contemporary trends in conduit selection in redo versus first-time coronary arterial bypass grafting and risk factors of mortality among patients with repeat bypasses. METHODS: Using the 2016-2021 Nationwide Readmissions Database, we identified adult patients undergoing isolated coronary arterial bypass grafting, stratified into First-time and Redo cohorts. The primary outcome was in-hospital mortality; secondary outcomes included perioperative complications, postoperative length of stay, hospitalization costs, nonhome discharge, and 30-day nonelective readmissions. Temporal trends in conduit use (internal mammary artery, radial artery, and saphenous vein) were assessed. RESULTS: Among 928,925 patients, 5.3% underwent redo coronary arterial bypass grafting. From 2016 to 2021, the use of the internal mammary artery, radial artery, and saphenous vein increased in both cohorts (P < .001). Redo status was associated with higher likelihood of developing complications, longer length of stay (β + 6.2 days), and increased costs (β + $11,100), but lower odds of in-hospital mortality (adjusted odds ratio: 0.75). Internal mammary artery use was independently associated with reduced odds of mortality (adjusted odds ratio: 0.57). CONCLUSION: Redo coronary arterial bypass grafting is modestly increasing nationwide and remains associated with greater morbidity and resource use, compared with first-time coronary arterial bypass grafting. Nonetheless, adjusted mortality is lower in redo coronary arterial bypass grafting, potentially reflecting careful patient selection and intensive perioperative care. Arterial conduit use, especially internal mammary artery, may confer survival benefits and warrants further study in the redo setting.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Cho BS, Le NK, Coaston T, et al. National trends in conduit selection for redo coronary arterial bypass grafting. Surgery. 2026. PMID: 41512605. doi:10.1016/j.surg.2025.110043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。